Company: XXC
Filing Date: 2025-09-18
Form Type: F-1/A
Source: 0001213900-25-089077
Chunk: 341

Company: XINXU COPPER INDUSTRY TECHNOLOGY Ltd
Filing Date: 2025-09-18
Form: F-1/A
Chunk 341
---
 the number of consecutive non -inspectionyears required for triggering the prohibitions under the Holding Foreign Companies Accountable Act (the “HFCA Act”) as it was originally passed from three years to two, and thus, reduced the time before our shares may be prohibited from trading or delisted. Each year, the PCAOB will determine whether it can inspect and investigate completely audit firms in mainland China and Hong Kong, among other jurisdictions. Our auditor, Fortune CPA, Inc, headquartered in Garden Grove City, California, the United States, was not included in the determinations made by the PCAOB on December 16, 2021 and is currently subject to PCAOB inspections. If the PCAOB determines in the future that it no longer has full access to inspect and investigate completely accounting firms in certain jurisdictions and we use an accounting firm headquartered in one of such jurisdictions to issue an audit report on our financial statements filed with the SEC, we would be identified as an issuer identified by the SEC (“Commission -IdentifiedIssuer”) following the filing of the annual report on Form 20 -Ffor the relevant fiscal year. There can be no assurance that we would not be identified as a Commission -IdentifiedIssuer for any future fiscal year, and if we were so identified for two consecutive years, we would become subject to the prohibition on trading under the HFCA Act. See “ Risk Factors — Risks Related to Doing Business in China — Trading in our securities may be prohibited under the Holding Foreign Companies Accountable Act if the PCAOB determines that it is unable to inspect or investigate completely our auditor, and as a result, U.S. national securities exchanges, such as Nasdaq, may determine to delist our securities. The delisting of our ordinary shares, or the threat of their being delisted, may materially and adversely affect the value of your investment” on page 25. Investing in our securities involves a high degree of risk. See “ Risk Factors ” beginning on page 25. Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. The date of this prospectus is [•], 2025.

Summary of the Resale Offering

| ordinary shares being offered                                     |     | 3,900,000 shares.                                                                                                                                                                                                                               |
| ordinary shares outstanding immediately before this offering      |     | 20,000,000 shares.                                                                                                                                                                                                                              |
| ordinary shares to